Grimsley HE, Antczak M, Reddin IG, Weiler N, et al. Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers. Cancer Lett 2025 Apr 27:217754. doi: 10.1016/j.canlet.2025.217754.
PMID: 40300663